The Role of PET and PET/CT in Managing the Care of Lymphoma Patients
Autor: | David Gilmore, Westley C Evans, Jeffrey English |
---|---|
Rok vydání: | 2011 |
Předmět: |
Adult
medicine.medical_specialty Lymphoma Gallium Stage lymphoma Sensitivity and Specificity Fluorodeoxyglucose F18 immune system diseases Treatment plan hemic and lymphatic diseases Biopsy medicine Humans Radiology Nuclear Medicine and imaging Citrates Neoplasm Staging Retrospective Studies PET-CT Radiological and Ultrasound Technology medicine.diagnostic_test business.industry Remission Induction Retrospective cohort study General Medicine medicine.disease Positron-Emission Tomography Female Neoplasm staging Radiology Neoplasm Recurrence Local Radiopharmaceuticals Tomography X-Ray Computed Nuclear medicine business After treatment |
Zdroj: | Journal of Nuclear Medicine Technology. 39:190-194 |
ISSN: | 0091-4916 |
DOI: | 10.2967/jnmt.110.082982 |
Popis: | The clinical use of PET and PET/CT aids physicians and patients in developing lymphoma prognoses, specifically for Hodgkin disease and aggressive types of non-Hodgkin lymphoma. PET and PET/CT are used to initially stage lymphoma, restage disease, and check for remission or recurrence of malignant tissue after treatment. PET/CT is more sensitive and specific than CT alone and has better accuracy concerning lymphoma relapse and remission. In conjunction with other tests, such as blood laboratory work and biopsy, PET and PET/CT allow the lymphoma to be staged appropriately and treated correctly. Results from PET and PET/CT contribute to the formation of a specialized treatment plan that leads to the best possible care for each individual patient. PET and PET/CT positively affect the management of patients with lymphoma. |
Databáze: | OpenAIRE |
Externí odkaz: |